1. TFOS Ambassadors

Argentina

Cecilia Marini

Dr. Maria Cecilia Marini is an ophthalmologist specializing in cornea, ocular surface, and infectious eye diseases. She earned her Specialist and Master’s Degrees in Ophthalmology from the University of Buenos Aires and the Argentine Council of Ophthalmology, and obtained the Eye Bank Director Certification from the Pan-American Eye Bank Association. 

She serves as Chief of the Corneal Transplant Division and Coordinator of Cornea and External Disease at the High Complexity Hospital El Cruce, and is part of the Cornea and Ocular Surface Section at the British Hospital of Buenos Aires. Dr. Marini is also Co-Director of the Integral Dry Eye Center (CIOS) and Associate Professor at the University of Salvador (USAL), where she participates in the ophthalmology specialist training program. 

Dr. Marini is an active member and part of the Board Member of the Argentine Ocular Surface Society (SASO) and the Argentine Ambassador for the Tear Film & Ocular Surface Society (TFOS). She contributed to the TFOS DEWS II Report and the TFOS Lifestyle Report. Her active involvement in national and international societies reflects her commitment to advancing clinical research, surgery and education in ocular surface medicine. 

Her scientific work focuses on dry eye disease epidemiology, ocular surface therapeutics (clinical and surgical) , and corneal infections. Some  publications include:
?    Epidemiology of Dry Eye Disease in Argentina (Springer, 2024)
?    Preservatives in Ophthalmic Formulations (OCE, 2024)
?    Efficacy and Toxicity Evaluation of Bepotastine Besilate 1.5% Preservative-Free Eye Drops vs. Olopatadine Hydrochloride 0.2% BAK-Preserved Eye Drops in Patients with Allergic Conjunctivitis (2023)
?    Ocular Rosacea. E-Book. (2018)
?    Ocular  Graft versus Host Disease. National Guidelines (2017)
?    Endophthalmitis, in Diagnostic Atlas of Retinal Disease (2017)
?    Anti-inflammatory Effects of Rebamipide Eye Drops on Superior Limbic Keratoconjunctivitis (2016)
?    Ultraviolet Irradiation (Cross-Linking) in the Treatment of Fungal Keratitis (2009)
?    Acanthamoeba Keratitis: Visual Rehabilitation (2009)
?    Author and co-author of book chapters on ocular surface disease, immunology, and corneal transplantation (CAO, SAO, SASO, CILAD).
?    Principal and sub-investigator in national and international multicenter clinical trials (2009–2025).

Through her clinical leadership, teaching, and research, Dr. Marini continues to contribute to the understanding and management of ocular surface diseases, always striving to improve outcomes and quality of life for her patients. 
< back

20 April

TFOS Guidelines

Ocular surface disease (OSD)—including dry eye disease, blepharitis, meibomian gland dysfunction, conjunctival inflammation, and cicatrizing ocular surface disorders—is one of the most common and underrecognized factors affecting the success of eye surgery (e.g., refractive, cataract, glaucoma, strabismus, retina, and oculoplastic). Conversely, optimizing the ocular surface is one of the most effective, modifiable strategies for enhancing surgical success across all ophthalmic subspecialties. And the central clinical principle appears to be universal: elective eye surgery...

17 April

EssilorLuxottica Partners with TFOS to Advance Ocular Surface Health Worldwide

TFOS is pleased to announce a new strategic partnership with EssilorLuxottica, a global leader in vision care and eyewear. This collaboration will support shared efforts to elevate awareness, education, and scientific progress in tear film and ocular surface health worldwide. By combining TFOS’s expertise in evidence-based consensus and professional education with EssilorLuxottica’s global reach and innovation capabilities, the partnership aims to help improve standards of care for patients affected by dry eye disease and related ocular surface conditions. Together, TFOS and EssilorLuxottica...

10 February

Latin American TFOS Ambassador Meeting

TFOS has organized a special meeting of the Latin American TFOS Ambassadors. This meeting, which will occur in Panama City this May, has two goals: first, to address the unmet needs for the management (e.g. diagnosis & treatment) of ocular surface diseases in their country/region, as well as what the Ambassadors perceive as short and long term scientific/clinical solutions; and second, to create a report for publication in a peer-reviewed journal. Participants will include TFOS Ambassadors from Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Ecuador, El Salvador, Guatemala, Honduras,...

Corporate Advisory Board Members